U.S. Approves Expanded Use of Tryngolza, Moving Treatment for Severe Hypertriglyceridemia Past the Pancreatitis Risk Threshold
The approval shifts the treatment goal from lowering lipid numbers toward preventing acute pancreatitis, but the clinical benefit still needs to be understood in the context of dietary control, long-term safety, and individual risk assessment.